Senior Associate

Janet Tang

Janet Tang specialises in the equity capital market.

• Relevant experience

• Clifford Chance advises on Ascentage Pharma's IPO under HKEX's new listing regime for biotech companies
  28 October 2019
  Client Work
• Clifford Chance advises on US$5 billion Hong Kong IPO of AB InBev's Asia business
  30 September 2019
  Client Work
• Clifford Chance advises on Hansoh Pharmaceutical's US$1 billion IPO
  14 June 2019
  Client Work
• 高伟绅为九江银行香港上市项目提供法律服务
  10 July 2018
  Client Work
• Clifford Chance advises Bank of Jiujiang on Hong Kong IPO
  10 July 2018
  Client Work
• Clifford Chance advises Bank of Jiujiang on Hong Kong IPO
  10 July 2018
  Client Work
• 高伟绅就小米47亿美元香港上市项目提供法律服务
  9 July 2018
  Client Work
• Clifford Chance advises on Xiaomi's US$4.7 billion IPO
  9 July 2018
  Client Work
• 高伟绅为平安好医生11.2亿美元上市提供法律服务
  4 May 2018
  Client Work
• Clifford Chance advises Ping An Good Doctor on US$1.12 billion IPO
  4 May 2018
  Client Work
• Clifford Chance advises on Postal Savings Bank of China's US$8 billion IPO, the largest this year globally
  14 September 2016
  Client Work
• 高伟绅为今年全球最大的首次公开发行 —— 中国邮政储蓄银行74亿美元发行
  14 September 2016
  Client Work
• Clifford Chance leads in Hong Kong IPOs for 2015
  31 December 2015
  Client Work

View more client work by this author